Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EsoBE: On-demand vs Continuous Esomeprazole in Barrett's Esophagus
NCT04329000Completed
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Feb 2010
- Primary completion
- Feb 2019
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of esomeprazole in Barrett's esophagus (2 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoints: Rates of progression, remaining unchanged, or regression of the distal esophageal metaplastic mucosa at 48 weeks, Total symptom day at 48 weeks and 1 more. Started Feb 2010; status: completed.
02
Drugs
esomeprazole
03
Conditions
Barrett's esophagus
Beyond the preview
Go deeper on NCT04329000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04329000.